Tolterodine tartrate 2 MG Oral Tablet — RxCUI 855194
RxNorm drug concept · Semantic clinical drug
RxCUI 855194
Semantic clinical drug · SCD
● Current RxNorm concept 14 FDA products
34 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI855194
Official nameTolterodine tartrate 2 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped14
Package NDCs mapped34
Reported Medicaid activity (SDUD)10,306 prescriptions · 32 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Tolterodine: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It treats overactive bladder, meaning sudden urges to urinate, leaking with those urges, and going very often. It helps calm the bladder muscle.
- It is taken by mouth. If you have the extended-release capsule, such as Detrol LA, take it once daily with water and swallow it whole. Follow your label and prescriber for your exa...
- Dry mouth is the most common. Headache, constipation, dizziness, stomach pain and dry or blurry eyes can also happen. Tell me if any of them bother you.
- Get emergency help for swelling of the face, lips or throat, or trouble breathing. Call your doctor if you cannot pass urine, or if you notice confusion, hallucinations, or a fast...
🕸️ Concept Web — How Tolterodine tartrate 2 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Tolterodine tartrate 2 MG Oral Tablet
RxCUI 855194 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Tolterodine
119565IN -
Tolterodine tartrate
221174PIN
-
Tolterodine
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Detrol
216511BN
-
Detrol
-
Dose forms 13
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Tolterodine Oral Tablet
374164SCDF -
Tolterodine tartrate Oral Tablet
2646989SCDFP -
Tolterodine Oral Product
1162744SCDG -
Tolterodine Pill
1162745SCDG -
Tolterodine tartrate Oral Product
2660956SCDGP -
Tolterodine tartrate Pill
2663550SCDGP -
Tolterodine Oral Tablet [Detrol]
368286SBDF -
Tolterodine tartrate Oral Tablet [Detrol]
2657301SBDFP - +5 more in this family
-
Tolterodine Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Tolterodine tartrate 2 MG
855181SCDC -
Tolterodine tartrate 2 MG Oral Tablet [Detrol]
855195SBD -
Tolterodine tartrate 2 MG [Detrol]
855183SBDC
-
Tolterodine tartrate 2 MG
Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Tolterodine tartrate 2 MG
SCDC · 855181 -
Tolterodine Oral Tablet
SCDF · 374164 -
Tolterodine tartrate Oral Tablet
SCDFP · 2646989 -
Tolterodine Oral Product
SCDG · 1162744 -
Tolterodine Pill
SCDG · 1162745 -
Tolterodine tartrate Oral Product
SCDGP · 2660956 -
Tolterodine tartrate Pill
SCDGP · 2663550
Brand-Name Concepts
-
Tolterodine tartrate 2 MG Oral Tablet [Detrol]
SBD · 855195 -
Tolterodine tartrate 2 MG [Detrol]
SBDC · 855183 -
Tolterodine Oral Tablet [Detrol]
SBDF · 368286 -
Tolterodine tartrate Oral Tablet [Detrol]
SBDFP · 2657301 -
Detrol Oral Product
SBDG · 1175215 -
Detrol Pill
SBDG · 1175216 -
Detrol
BN · 216511
📦 FDA Products & Package NDCs
14 products · 34 package NDCs
34 package NDCs map to RxCUI 855194 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00093-0010-06 | 60 TABLET, FILM COATED in 1 BOTTLE (0093-0010-06) | Tolterodine Tartrate | Teva Pharmaceuticals USA, Inc. | 2015-11-01 |
| 00093-0018-05 | 500 TABLET, FILM COATED in 1 BOTTLE (0093-0018-05) | Tolterodine Tartrate | Teva Pharmaceuticals USA, Inc. | 2015-11-01 |
| 00093-0018-06 | 60 TABLET, FILM COATED in 1 BOTTLE (0093-0018-06) | Tolterodine Tartrate | Teva Pharmaceuticals USA, Inc. | 2015-11-01 |
| 16571-0126-01 | 100 TABLET, FILM COATED in 1 BOTTLE (16571-126-01) | Tolterodine Tartrate | Rising Pharma Holdings, Inc. | 2020-01-24 |
| 16571-0126-06 | 60 TABLET, FILM COATED in 1 BOTTLE (16571-126-06) | Tolterodine Tartrate | Rising Pharma Holdings, Inc. | 2020-01-24 |
| 16571-0126-50 | 500 TABLET, FILM COATED in 1 BOTTLE (16571-126-50) | Tolterodine Tartrate | Rising Pharma Holdings, Inc. | 2020-01-24 |
| 16571-0127-01 | 100 TABLET, FILM COATED in 1 BOTTLE (16571-127-01) | Tolterodine Tartrate | Rising Pharma Holdings, Inc. | 2020-01-24 |
| 16571-0127-06 | 60 TABLET, FILM COATED in 1 BOTTLE (16571-127-06) | Tolterodine Tartrate | Rising Pharma Holdings, Inc. | 2020-01-24 |
| 16571-0127-50 | 500 TABLET, FILM COATED in 1 BOTTLE (16571-127-50) | Tolterodine Tartrate | Rising Pharma Holdings, Inc. | 2020-01-24 |
| 29300-0239-05 | 500 TABLET in 1 BOTTLE, PLASTIC (29300-239-05) | Tolterodine Tartrate | Unichem Pharmaceuticals (USA), Inc. | 2020-08-05 |
| 29300-0239-16 | 60 TABLET in 1 BOTTLE, PLASTIC (29300-239-16) | Tolterodine Tartrate | Unichem Pharmaceuticals (USA), Inc. | 2020-08-05 |
| 29300-0240-01 | 100 TABLET in 1 BOTTLE, PLASTIC (29300-240-01) | Tolterodine Tartrate | Unichem Pharmaceuticals (USA), Inc. | 2020-08-05 |
| 29300-0240-05 | 500 TABLET in 1 BOTTLE, PLASTIC (29300-240-05) | Tolterodine Tartrate | Unichem Pharmaceuticals (USA), Inc. | 2020-08-05 |
| 29300-0240-13 | 30 TABLET in 1 BOTTLE, PLASTIC (29300-240-13) | Tolterodine Tartrate | Unichem Pharmaceuticals (USA), Inc. | 2020-08-05 |
| 29300-0240-16 | 60 TABLET in 1 BOTTLE, PLASTIC (29300-240-16) | Tolterodine Tartrate | Unichem Pharmaceuticals (USA), Inc. | 2020-08-05 |
| 29300-0240-19 | 90 TABLET in 1 BOTTLE, PLASTIC (29300-240-19) | Tolterodine Tartrate | Unichem Pharmaceuticals (USA), Inc. | 2020-08-05 |
| 31722-0805-01 | 10 BLISTER PACK in 1 CARTON (31722-805-01) / 10 TABLET, FIL... | Tolterodine Tartrate | Camber Pharmaceuticals, Inc. | 2021-08-02 |
| 31722-0805-02 | 10 BLISTER PACK in 1 CARTON (31722-805-02) / 10 TABLET, FIL... | Tolterodine Tartrate | Camber Pharmaceuticals, Inc. | 2021-08-02 |
| 31722-0805-05 | 500 TABLET, FILM COATED in 1 BOTTLE (31722-805-05) | Tolterodine Tartrate | Camber Pharmaceuticals, Inc. | 2021-08-02 |
| 31722-0805-60 | 60 TABLET, FILM COATED in 1 BOTTLE (31722-805-60) | Tolterodine Tartrate | Camber Pharmaceuticals, Inc. | 2021-08-02 |
| 31722-0806-01 | 10 BLISTER PACK in 1 CARTON (31722-806-01) / 10 TABLET, FIL... | Tolterodine Tartrate | Camber Pharmaceuticals, Inc. | 2021-08-02 |
| 31722-0806-02 | 10 BLISTER PACK in 1 CARTON (31722-806-02) / 10 TABLET, FIL... | Tolterodine Tartrate | Camber Pharmaceuticals, Inc. | 2021-08-02 |
| 31722-0806-05 | 500 TABLET, FILM COATED in 1 BOTTLE (31722-806-05) | Tolterodine Tartrate | Camber Pharmaceuticals, Inc. | 2021-08-02 |
| 31722-0806-60 | 60 TABLET, FILM COATED in 1 BOTTLE (31722-806-60) | Tolterodine Tartrate | Camber Pharmaceuticals, Inc. | 2021-08-02 |
| 33342-0097-09 | 60 TABLET, FILM COATED in 1 BOTTLE (33342-097-09) | Tolterodine tartrate | Macleods Pharmaceuticals Limited | 2020-10-08 |
| 33342-0097-12 | 10 BLISTER PACK in 1 CARTON (33342-097-12) / 10 TABLET, FIL... | Tolterodine tartrate | Macleods Pharmaceuticals Limited | 2020-10-08 |
| 33342-0097-15 | 500 TABLET, FILM COATED in 1 BOTTLE (33342-097-15) | Tolterodine tartrate | Macleods Pharmaceuticals Limited | 2020-10-08 |
| 33342-0098-09 | 60 TABLET, FILM COATED in 1 BOTTLE (33342-098-09) | Tolterodine tartrate | Macleods Pharmaceuticals Limited | 2020-10-08 |
| 33342-0098-12 | 10 BLISTER PACK in 1 CARTON (33342-098-12) / 10 TABLET, FIL... | Tolterodine tartrate | Macleods Pharmaceuticals Limited | 2020-10-08 |
| 33342-0098-15 | 500 TABLET, FILM COATED in 1 BOTTLE (33342-098-15) | Tolterodine tartrate | Macleods Pharmaceuticals Limited | 2020-10-08 |
| 58151-0098-91 | 60 TABLET, FILM COATED in 1 BOTTLE (58151-098-91) | Detrol | Viatris Specialty LLC | 2024-05-21 |
| 58151-0099-91 | 60 TABLET, FILM COATED in 1 BOTTLE (58151-099-91) | Detrol | Viatris Specialty LLC | 2024-08-01 |
| 59762-0170-06 | 60 TABLET, FILM COATED in 1 BOTTLE (59762-0170-6) | Tolterodine Tartrate | Mylan Pharmaceuticals Inc. | 2014-01-21 |
| 59762-0800-06 | 500 TABLET, FILM COATED in 1 BOTTLE (59762-0800-6) | Tolterodine Tartrate | Mylan Pharmaceuticals Inc. | 2014-01-21 |
Observed labelers:
Camber Pharmaceuticals, Inc. (8) ·
Unichem Pharmaceuticals (USA), Inc. (7) ·
Macleods Pharmaceuticals Limited (6) ·
Rising Pharma Holdings, Inc. (6) ·
Teva Pharmaceuticals USA, Inc. (3) ·
Mylan Pharmaceuticals Inc. (2)
· +1 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.